| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |